These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 19293782)

  • 21. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
    Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
    Schindhelm RK; Diamant M; Bakker SJ; van Dijk RA; Scheffer PG; Teerlink T; Kostense PJ; Heine RJ
    Eur J Clin Invest; 2005 Jun; 35(6):369-74. PubMed ID: 15948897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship of liver fat content to insulin resistance and metabolic syndrome].
    Yan HM; Gao X; Liu M; Gu Q; Zhang B; Li X
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1255-8. PubMed ID: 18844098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    J Hepatol; 2007 Apr; 46(4):700-7. PubMed ID: 17150278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
    Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
    Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
    Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
    Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
    Shieh K; Gilchrist JM; Promrat K
    Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
    Ong JP; Pitts A; Younossi ZM
    J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.
    Choi SY; Kim D; Kim HJ; Kang JH; Chung SJ; Park MJ; Kim YS; Kim CH; Choi SH; Kim W; Kim YJ; Yoon JH; Lee HS; Cho SH; Sung MW; Oh BH
    Am J Gastroenterol; 2009 Aug; 104(8):1953-60. PubMed ID: 19491838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
    Halimi JM; Bonnet F; Lange C; Balkau B; Tichet J; Marre M;
    J Hypertens; 2008 Nov; 26(11):2198-206. PubMed ID: 18854761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.